Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women.

Latka MH, Fielding K, Gray GE, Bekker LG, Nchabeleng M, Mlisana K, Nielson T, Roux S, Mkhize B, Mathebula M, Naicker N, de Bruyn G, Kublin J, Churchyard GJ; HVTN 503 Phambili study team.

PLoS One. 2012;7(4):e31387. doi: 10.1371/journal.pone.0031387. Epub 2012 Apr 19.

2.

Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.

Moodie Z, Metch B, Bekker LG, Churchyard G, Nchabeleng M, Mlisana K, Laher F, Roux S, Mngadi K, Innes C, Mathebula M, Allen M, Bentley C, Gilbert PB, Robertson M, Kublin J, Corey L, Gray GE.

PLoS One. 2015 Sep 14;10(9):e0137666. doi: 10.1371/journal.pone.0137666. eCollection 2015.

3.

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.

Gray GE, Moodie Z, Metch B, Gilbert PB, Bekker LG, Churchyard G, Nchabeleng M, Mlisana K, Laher F, Roux S, Mngadi K, Innes C, Mathebula M, Allen M, McElrath MJ, Robertson M, Kublin J, Corey L; HVTN 503/Phambili study team.

Lancet Infect Dis. 2014 May;14(5):388-96. doi: 10.1016/S1473-3099(14)70020-9. Epub 2014 Feb 20.

4.

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

Gray GE, Allen M, Moodie Z, Churchyard G, Bekker LG, Nchabeleng M, Mlisana K, Metch B, de Bruyn G, Latka MH, Roux S, Mathebula M, Naicker N, Ducar C, Carter DK, Puren A, Eaton N, McElrath MJ, Robertson M, Corey L, Kublin JG; HVTN 503/Phambili study team.

Lancet Infect Dis. 2011 Jul;11(7):507-15. doi: 10.1016/S1473-3099(11)70098-6. Epub 2011 May 11. Erratum in: Lancet Infect Dis. 2011 Jul;11(7):495.

5.

Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.

Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, Watts DH, Marrazzo JM; VOICE Study Team.

Lancet HIV. 2015 Jul;2(7):e279-87.

6.

Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa.

Otwombe KN, Sikkema KJ, Dietrich J, de Bruyn G, van der Watt M, Gray GE.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):211-8. doi: 10.1097/QAI.0b013e31822b7702.

7.

Pregnancy incidence and correlates in a clinical trial preparedness study, North West Province South Africa.

Chetty-Makkan CM, Fielding K, Feldblum PJ, Price MA, Kruger P, Makkan H, Charalambous S, Latka MH.

PLoS One. 2014 May 6;9(5):e95708. doi: 10.1371/journal.pone.0095708. eCollection 2014.

8.

[Current status of the female condom in Africa].

Deniaud F.

Sante. 1997 Nov-Dec;7(6):405-15. Review. French.

PMID:
9503499
9.

Early adolescent pregnancy increases risk of incident HIV infection in the Eastern Cape, South Africa: a longitudinal study.

Christofides NJ, Jewkes RK, Dunkle KL, Nduna M, Shai NJ, Sterk C.

J Int AIDS Soc. 2014 Mar 19;17:18585. doi: 10.7448/IAS.17.1.18585. eCollection 2014.

10.

Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. DITRAME ANRS 049 Project, Abidjan 1995-2000.

Desgrées-Du-Loû A, Msellati P, Viho I, Yao A, Yapi D, Kassi P, Welffens-Ekra C, Mandelbrot L, Dabis F; Ditrame Study Group.

Int J STD AIDS. 2002 Jul;13(7):462-8.

PMID:
12171665
11.

Pregnancy in HIV clinical trials in Sub Saharan Africa: failure of consent or contraception?

Ssali A, Namukwaya S, Bufumbo L, Seeley J, G Lalloo D, Kamali A, Parkes-Ratanshi R.

PLoS One. 2013 Sep 10;8(9):e73556. doi: 10.1371/journal.pone.0073556. eCollection 2013.

12.

Pregnancy and contraceptive use among women participating in an HIV prevention trial in Tanzania.

Odutola A, Baisley K, Hayes RJ, Rusizoka M, Tanton C, Weiss HA, Changalucha J, Ross DA, Watson-Jones D.

Sex Transm Infect. 2012 Oct;88(6):436-43. Epub 2012 Mar 21.

13.

Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial.

Crook AM, Ford D, Gafos M, Hayes R, Kamali A, Kapiga S, Nunn A, Chisembele M, Ramjee G, Rees H, McCormack S.

Hum Reprod. 2014 Aug;29(8):1810-7. doi: 10.1093/humrep/deu113. Epub 2014 May 16.

14.

Contraceptive use in women enrolled into preventive HIV vaccine trials: experience from a phase I/II trial in East Africa.

Kibuuka H, Guwatudde D, Kimutai R, Maganga L, Maboko L, Watyema C, Sawe F, Shaffer D, Matsiko D, Millard M, Michael N, Wabwire-Mangen F, Robb M.

PLoS One. 2009;4(4):e5164. doi: 10.1371/journal.pone.0005164. Epub 2009 Apr 10.

15.

Contraception use and impact on pregnancy prevention in women participating in an HIV prevention trial in South Africa.

Moodley J, Naidoo S, Wand H, Ramjee G; Microbicides Development Programme team.

J Fam Plann Reprod Health Care. 2016 Jan;42(1):5-11. doi: 10.1136/jfprhc-2014-101100. Epub 2015 Aug 10.

PMID:
26259895
16.

Unintended pregnancy among HIV positive couples receiving integrated HIV counseling, testing, and family planning services in Zambia.

Wall KM, Haddad L, Vwalika B, Htee Khu N, Brill I, Kilembe W, Stephenson R, Chomba E, Vwalika C, Tichacek A, Allen S.

PLoS One. 2013 Sep 30;8(9):e75353. doi: 10.1371/journal.pone.0075353. eCollection 2013.

17.

Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women.

Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, Cowan FM, Delany-Moretlwe S, Baeten JM, Hughes JP, Wald A, Celum C.

J Acquir Immune Defic Syndr. 2010 Apr;53(5):606-13. doi: 10.1097/QAI.0b013e3181bc4869.

18.

Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa.

McCoy SI, Zheng W, Montgomery ET, Blanchard K, van der Straten A, de Bruyn G, Padian NS.

AIDS. 2013 Mar 27;27(6):1001-9. doi: 10.1097/QAD.0b013e32835da401.

PMID:
23698064
19.

African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial.

Venkatesh KK, van der Straten A, Mayer KH, Blanchard K, Ramjee G, Lurie MN, Chipato T, Padian NS, de Bruyn G.

Sex Transm Dis. 2011 Jun;38(6):562-70. doi: 10.1097/OLQ.0b013e31820a8c2c.

PMID:
21278624
20.

Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study.

Jewkes RK, Dunkle K, Nduna M, Shai N.

Lancet. 2010 Jul 3;376(9734):41-8. doi: 10.1016/S0140-6736(10)60548-X.

Items per page

Supplemental Content

Write to the Help Desk